Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers
PaperCitations, authors & open-access status
Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 37 citations, 2017 year and closed oa status.
37
Citations
2017
Year
closed
OA Status